List of bibliographic references indexed by overview
Number of relevant bibliographic references: 20.
Ident. | Authors (with country if any) | Title |
---|
000104 (2021) |
Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban] | The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19. |
000176 (2021) |
Hareesh Krishnan [Inde] ; M. Leema [Inde] ; G S Gopika [Inde] ; P M Hari Prasad [Inde] ; Abhilash Rajan [Inde] ; Arathy Anil [Inde] ; Anandhu P. Dev [Inde] ; Zeena S. Pillai [Inde] | SARS CoV-2: Progression and Treatment Protocols- An Overview. |
000227 (2021) |
Iwein Gyselinck [Belgique] ; Wim Janssens [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] | Rationale for azithromycin in COVID-19: an overview of existing evidence. |
000646 (2021) |
Veera B. Pallaval [Inde] ; Manasa Kanithi [États-Unis] ; Sangeetha Meenakshisundaram [Inde] ; Achanta Jagadeesh [Corée du Sud] ; Mattareddy Alavala [Inde] ; Thanigaimalai Pillaiyar [Allemagne] ; Manoj Manickam [Inde] ; Bojjibabu Chidipi [États-Unis] | Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents. |
000740 (2021) |
Viktorija Dragojevic Simic [Serbie] ; Milijana Miljkovic [Serbie] ; Dusica Stamenkovic [Serbie] ; Berislav Vekic [Serbie] ; Nenad Ratkovic [Serbie] ; Radoje Simic [Serbie] ; Nemanja Rancic [Serbie] | An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine. |
000745 (2021) |
Yamei Zhang [Irlande (pays)] ; Siobhan Gargan [Irlande (pays)] ; Yongxu Lu [Royaume-Uni] ; Nigel J. Stevenson [Irlande (pays), Bahreïn] | An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity. |
000786 (2021) |
Muhammad Harris Shoaib [Pakistan] ; Farrukh Rafiq Ahmed [Pakistan] ; Muhammad Sikandar [Pakistan] ; Rabia Ismail Yousuf [Pakistan] ; Muhammad Talha Saleem [Pakistan] | A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management. |
000841 (2020) |
Narayan Prasad [Inde] ; N. Gopalakrishnan [Inde] ; Manisha Sahay [Inde] ; Amit Gupta [Inde] ; Sanjay K. Agarwal [Inde] | Epidemiology, Genomic Structure, the Molecular Mechanism of Injury, Diagnosis and Clinical Manifestations of Coronavirus Infection: An Overview. |
000855 (2020) |
Dinesh Kaul [Inde] | An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications. |
000E83 (2020) |
Muhammad S. Mian ; Laiba Razaq ; Safeera Khan [États-Unis] ; Nadia Hussain ; Mahrukh Razaq | Pathological Findings and Management of COVID-19 Patients: A Brief Overview of Modern-day Pandemic. |
000E91 (2020) |
Heng Li [République populaire de Chine] ; Li Yang [République populaire de Chine] ; Fei-Fei Liu [République populaire de Chine] ; Xin-Na Ma [République populaire de Chine] ; Pei-Lan He [République populaire de Chine] ; Wei Tang [République populaire de Chine] ; Xian-Kun Tong [République populaire de Chine] ; Jian-Ping Zuo [République populaire de Chine] | Overview of therapeutic drug research for COVID-19 in China. |
000E92 (2020) |
Christian Voto [États-Unis] ; Paul Berkner [États-Unis] ; Carol Brenner [États-Unis] | Overview of the Pathogenesis and Treatment of SARS-CoV-2 for Clinicians: A Comprehensive Literature Review. |
000E93 (2020) |
Maria Laura Idda [Italie] ; Dorian Soru [Italie] ; Matteo Floris [Italie] | Overview of the First 6 Months of Clinical Trials for COVID-19 Pharmacotherapy: The Most Studied Drugs. |
000F20 (2020) |
Fatemeh Oroojalian [Iran] ; Ali Haghbin [Iran] ; Behzad Baradaran [Iran] ; Nima Hemmat [Iran] ; Mohammad-Ali Shahbazi [Iran] ; Hossein Bannazadeh Baghi [Iran] ; Ahad Mokhtarzadeh [Iran] ; Michael R. Hamblin [Afrique du Sud] | Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials. |
001440 (2020) |
Mehmet Soy [Turquie] ; Gökhan Keser [Turquie] ; Pamir Atagündüz [Turquie] ; Fehmi Tabak [Turquie] ; I K Atagündüz [Turquie] ; Servet Kayhan [Turquie] | Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. |
001723 (2020) |
Jean Jacques Vanden Eynde [Belgique] | COVID-19: A Brief Overview of the Discovery Clinical Trial. |
001744 (2020) |
Haneen Amawi ; Ghina'A I. Abu Deiab ; Alaa A. A Aljabali ; Kamal Dua [Australie] ; Murtaza M. Tambuwala [Royaume-Uni] | COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. |
001821 (2020) |
Bin Wang [République populaire de Chine] ; Junkai Lai [République populaire de Chine] ; Xiaoyan Yan [République populaire de Chine] ; Feifei Jin [République populaire de Chine] ; Bin Yi [République populaire de Chine] ; Caixia An [République populaire de Chine] ; Yuanxiao Li [République populaire de Chine] ; Chen Yao [République populaire de Chine] | COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis. |
001906 (2020) |
Manal A. Hamed [Égypte] | An overview on COVID-19: reality and expectation. |
001907 (2020) |
Dongyuan Wang [République populaire de Chine] ; Zigang Li [République populaire de Chine] ; Yihui Liu [République populaire de Chine] | An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "overview"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "overview" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= overview
}}
| This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 | ![](Common/icons/LogoDilib.gif) |